novo nordisk semaglutide direct faces 'must-win' battle over U.S. Wegovy, Ozempic in 2026 Novo Nordisk medicines containing semaglutide

Incorporate a Healthy Diet and Physical Activity: Diet and exercise are the cornerstones of diabetes management and can enhance the effects of GLP-1 agonist alternatives

Digestive Challenges with GLP-1 Agonists Up to 70% of GLP-1 users struggle with GI discomfort, including nausea, vomiting and diarrhea

A 2024 study by Hathaway et al., which investigated more than 16,000 patients over a period of six years, raised ocular safety issues related to semaglutide

One of the studies it examined, from 2020, found that 67 percent of its sample were obese, of whom 15 percent died as a result of infection

22 GLP-1 secretion plays a critical role in regulating various homeostatic mechanisms, 3,20 some of which overlap between peripheral and central GLP-1 systems